Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy
- PMID: 36748180
- DOI: 10.1111/bju.15984
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy
Abstract
Objectives: To evaluate variant histologies (VHs) for disease-specific survival (DSS) in patients with invasive urothelial bladder cancer (BCa) undergoing radical cystectomy (RC).
Materials and methods: We analysed a multi-institutional cohort of 1082 patients treated with upfront RC for cT1-4aN0M0 urothelial BCa at eight centres. Univariable and multivariable Cox' regression analyses were used to assess the effect of different VHs on DSS in overall cohort and three stage-based analyses. The stages were defined as 'organ-confined' (≤pT2N0), 'locally advanced' (pT3-4N0) and 'node-positive' (pTanyN1-3).
Results: Overall, 784 patients (72.5%) had pure urothelial carcinoma (UC), while the remaining 298 (27.5%) harboured a VH. Squamous differentiation was the most common VH, observed in 166 patients (15.3%), followed by micropapillary (40 patients [3.7%]), sarcomatoid (29 patients [2.7%]), glandular (18 patients [1.7%]), lymphoepithelioma-like (14 patients [1.3%]), small-cell (13 patients [1.2%]), clear-cell (eight patients [0.7%]), nested (seven patients [0.6%]) and plasmacytoid VH (three patients [0.3%]). The median follow-up was 2.3 years. Overall, 534 (49.4%) disease-related deaths occurred. In uni- and multivariable analyses, plasmacytoid and small-cell VHs were associated with worse DSS in the overall cohort (both P = 0.04). In univariable analyses, sarcomatoid VH was significantly associated with worse DSS, while lymphoepithelioma-like VH had favourable DSS compared to pure UC. Clear-cell (P = 0.015) and small-cell (P = 0.011) VH were associated with worse DSS in the organ-confined and node-positive cohorts, respectively.
Conclusions: More than 25% of patients harboured a VH at time of RC. Compared to pure UC, clear-cell, plasmacytoid, small-cell and sarcomatoid VHs were associated with worse DSS, while lymphoepithelioma-like VH was characterized by a DSS benefit. Accurate pathological diagnosis of VHs may ensure tailored counselling to identify patients who require more intensive management.
Keywords: #BladderCancer; #blcsm; #uroonc; #utuc; bladder urothelial carcinoma; prognosis; radical cystectomy; survival; variant histology.
© 2023 BJU International.
Similar articles
-
Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy.Eur Urol Focus. 2022 Mar;8(2):457-464. doi: 10.1016/j.euf.2021.04.005. Epub 2021 Apr 16. Eur Urol Focus. 2022. PMID: 33867307
-
Impact of variant histology on upstaging and survival in patients with nonmuscle invasive bladder cancer undergoing radical cystectomy.Urol Oncol. 2024 Mar;42(3):69.e11-69.e16. doi: 10.1016/j.urolonc.2023.12.008. Epub 2024 Jan 23. Urol Oncol. 2024. PMID: 38267301
-
The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy.Eur Urol Focus. 2019 Jan;5(1):104-108. doi: 10.1016/j.euf.2017.06.013. Epub 2017 Jun 27. Eur Urol Focus. 2019. PMID: 28753857 Free PMC article.
-
What Is the Significance of Variant Histology in Urothelial Carcinoma?Eur Urol Focus. 2020 Jul 15;6(4):653-663. doi: 10.1016/j.euf.2019.09.003. Epub 2019 Sep 15. Eur Urol Focus. 2020. PMID: 31530497 Review.
-
Impact of Variant Histology on Occult Nodal Metastasis after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Review of the National Cancer Database.Clin Genitourin Cancer. 2022 Apr;20(2):e135-e139. doi: 10.1016/j.clgc.2021.11.011. Epub 2021 Dec 1. Clin Genitourin Cancer. 2022. PMID: 34961704 Review.
Cited by
-
The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature.J Clin Med. 2024 Jul 25;13(15):4349. doi: 10.3390/jcm13154349. J Clin Med. 2024. PMID: 39124615 Free PMC article. Review.
-
Case report: Toripalimab plus anlotinib in postoperative recurrent renal pelvic sarcomatoid urothelial carcinoma.Front Oncol. 2024 Sep 25;14:1397855. doi: 10.3389/fonc.2024.1397855. eCollection 2024. Front Oncol. 2024. PMID: 39386196 Free PMC article.
-
Treatment Patterns and Radical Cystectomy Outcomes in Patients Diagnosed With Urothelial Nonmetastatic Muscle-Invasive Bladder Cancer in the United States.Cancer Med. 2025 Feb;14(4):e70644. doi: 10.1002/cam4.70644. Cancer Med. 2025. PMID: 39945337 Free PMC article.
-
An Unusual Presentation of Bladder Carcinoma in a Visceral Hernia: A Case Report and Literature Review.Cancer Rep (Hoboken). 2025 Feb;8(2):e70128. doi: 10.1002/cnr2.70128. Cancer Rep (Hoboken). 2025. PMID: 39894891 Free PMC article. Review.
-
Strategies for Overcoming Immune Evasion in Bladder Cancer.Int J Mol Sci. 2024 Mar 7;25(6):3105. doi: 10.3390/ijms25063105. Int J Mol Sci. 2024. PMID: 38542078 Free PMC article. Review.
References
-
- Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin 2021; 71: 7-33
-
- Witjes JA, Bruins HM, Cathomas R et al. European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: Summary of the 2020 guidelines. Eur Urol 2021; 79: 82-104
-
- Yu EY, Liu Y, Chen Y et al. The effects of the interaction of genetic predisposition with lifestyle factors on bladder cancer risk. BJU Int 2022. https://doi.org/10.1111/bju.15880
-
- Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO classification of Tumours of the urinary system and male genital organs-Part B: Prostate and bladder Tumours. Eur Urol 2016; 70: 106-19
-
- Lobo N, Shariat SF, Guo CC et al. What is the significance of variant histology in urothelial carcinoma? Eur Urol Focus 2020; 6: 653-63
MeSH terms
LinkOut - more resources
Full Text Sources
Medical